About Danjuma Quarless
Form D filings for Oisin Biotechnologies in 2024 list Danjuma Quarless as director.
Danjuma Quarless first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Danjuma Quarless in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Danjuma Quarless works with at each company, as listed on that company's latest Form D.
Oisin Biotechnologies, Inc. · Form D, Jul 12, 2024
EG
Eric Garcia
Executive officer
MS
Matthew Scholz
President & CEO, director
DG
David Gobel
Director
SH
Stephen Hilbert
Executive officer
JL
John Lewis
Executive officer
GH
Gary Hudson
Executive officer and director